In Thursday’s Wall Street session, Ocugen Inc (NASDAQ:OCGN) shares traded at $1.15, up 1.77% from the previous session.
OCGN stock price is now 25.95% away from the 50-day moving average and 38.75% away from the 200-day moving average. The market capitalization of the company currently stands at $335.84M.
With the price target of $4, Maxim Group recently initiated with Buy rating for Ocugen Inc (NASDAQ: OCGN). On March 01, 2023, Chardan Capital Markets Upgraded its previous ‘Neutral’ rating to ‘Buy’ on the stock keeping its target price maintained at $3.50, while ‘Mizuho’ rates the stock as ‘Buy’
In other news, MARNA C. WHITTINGTON, Director bought 112,205 shares of the company’s stock on Jul 09 ’25. The stock was bought for $122,887 at an average price of $1.10. An SEC document containing details of the transaction can be found on the SEC’s website. On Jun 11 ’25, Director PRABHAVATHI FERNANDES bought 146,705 shares of the business’s stock. A total of $171,029 was incurred on buying the stock at an average price of $1.17. A total of 1.80% of the company’s stock is owned by insiders.
During the past 12 months, Ocugen Inc has had a low of $0.51 and a high of $1.98. As of last week, the company has a debt-to-equity ratio of 2.00, a current ratio of 2.60, and a quick ratio of 2.60. The fifty day moving average price for OCGN is $0.91302 and a two-hundred day moving average price translates $0.82882 for the stock.
The latest earnings results from Ocugen Inc (NASDAQ: OCGN) was released for 2025-03-31. The net profit margin was -1160.86% and return on equity was -248.97% for OCGN. The company reported revenue of $1.48 million for the quarter, compared to $1.01 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 46.06 percent.
